99 related articles for article (PubMed ID: 30496575)
1. The generation and biological activity of a long-lasting recombinant human interferon-λ1.
Yuan WM; Zhang R; Zhang Q; Ma FL; Wang C; Wang YZ; Zeng Y; Zheng LS
Protein Eng Des Sel; 2018 Sep; 31(9):355-360. PubMed ID: 30496575
[TBL] [Abstract][Full Text] [Related]
2. Development and biological activity of long-acting recombinant human interferon-α2b.
Zhang Q; Wang C; Ma F; Yao L; Gao H; Zhu L; Zheng L
BMC Biotechnol; 2020 Mar; 20(1):16. PubMed ID: 32169063
[TBL] [Abstract][Full Text] [Related]
3. IFN-λ1 in CHO cells: its expression and biological activity.
Yuan WM; Zhang WJ; Ma FL; Li JS; Zhang Q; Zheng LS
Cell Mol Biol Lett; 2017; 22():26. PubMed ID: 29213292
[TBL] [Abstract][Full Text] [Related]
4. Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit.
Ceaglio N; Gugliotta A; Tardivo MB; Cravero D; Etcheverrigaray M; Kratje R; Oggero M
J Biotechnol; 2016 Mar; 221():13-24. PubMed ID: 26806490
[TBL] [Abstract][Full Text] [Related]
5. Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics.
Li J; Li B; Zhang J; Hou L; Yu C; Fu L; Song X; Yu T; Zhang J; Ren J; Xu C; Chen W
Antiviral Res; 2011 Mar; 89(3):199-203. PubMed ID: 21277904
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and characterization of human IFN-lambda1 in Pichia pastoris.
Xie YF; Chen H; Huang BR
J Biotechnol; 2007 May; 129(3):472-80. PubMed ID: 17349709
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activities of recombinant human interferon (IFN)-λ1 in vitro and in xenograft models in vivo for colon cancer.
Hui X; Chen H; Zhang S; Ma X; Wang X; Huang B
Cancer Lett; 2011 Dec; 311(2):141-51. PubMed ID: 21872388
[TBL] [Abstract][Full Text] [Related]
8. [Expression, purification and characterization of N-glycosylation mutant human IFN-λ1 in Pichia pastoris].
Hui X; Chen H; Huang B
Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):613-624. PubMed ID: 29701035
[TBL] [Abstract][Full Text] [Related]
9. Prokaryotic expression of soluble IFN-λ1 recombinant protein with cold-shock system.
Ren L; Meng X; Sun J; Shao X; Shao M; Wang S; Li Z; Chen Y
Protein Expr Purif; 2024 Mar; 215():106413. PubMed ID: 38065246
[TBL] [Abstract][Full Text] [Related]
10. Anti-H7N9 avian influenza A virus activity of interferon in pseudostratified human airway epithelium cell cultures.
Chen AJ; Dong J; Yuan XH; Bo H; Li SZ; Wang C; Duan ZJ; Zheng LS
Virol J; 2019 Apr; 16(1):44. PubMed ID: 30944006
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and antiproliferative effects of canine interferon-λ1.
Ichihashi T; Asano A; Usui T; Takeuchi T; Watanabe Y; Yamano Y
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):141-6. PubMed ID: 24126210
[TBL] [Abstract][Full Text] [Related]
12. Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes.
Peng FW; Duan ZJ; Zheng LS; Xie ZP; Gao HC; Zhang H; Li WP; Hou YD
Protein Expr Purif; 2007 Jun; 53(2):356-62. PubMed ID: 17287131
[TBL] [Abstract][Full Text] [Related]
13. [Cloning, expression and purification of interferon-kappa, a novel human interferon, and its antiviral activity].
Zhang H; Duan ZJ; Zhu JG; Peng FW; Li WP; Gao HC; Xie ZP; Wang YE; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):223-6. PubMed ID: 16261202
[TBL] [Abstract][Full Text] [Related]
14. [Biological activities of recombinant human interferon Epsilon].
Peng FW; Gao HC; Xie ZP; Zhang H; Li QM; Duan ZJ; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):227-31. PubMed ID: 16261203
[TBL] [Abstract][Full Text] [Related]
15. PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics.
Yu W; Yu C; Wu L; Fang T; Qiu R; Zhang J; Yu T; Fu L; Chen W; Hu T
Antiviral Res; 2014 Aug; 108():142-7. PubMed ID: 24936771
[TBL] [Abstract][Full Text] [Related]
16. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach.
Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM
Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090
[TBL] [Abstract][Full Text] [Related]
17. Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG.
Furuhashi M; Shikone T; Fares FA; Sugahara T; Hsueh AJ; Boime I
Mol Endocrinol; 1995 Jan; 9(1):54-63. PubMed ID: 7539107
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli.
Yan X; Hu S; Guan YX; Yao SJ
Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
